Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
01 1Granules India Limited
02 2Sichuan Elixir Pharmaceuticals
03 1ChemWerth Inc
04 1Transo-Pharm USA LLC
05 1LGM Pharma
06 1Fermion Oy
07 3Dr. Reddy's Laboratories
08 1Tagoor Laboratories
09 1Alembic Pharmaceuticals Limited
10 1Aurobindo Pharma Limited
11 1Baran Chemical and Pharmaceutical
12 1Beijing Mesochem Technology
13 1Biocon
14 1Guangzhou Tosun Pharmaceutical
15 1Hetero Drugs
16 1Hunan Huateng Pharmaceutical Co ltd
17 2MSN Laboratories
18 1Natco Pharma
19 1Shandong Haohong Biotechnology Co.,ltd
20 1Shanghai Hope Chem
21 1Shenzhen Haorui
22 1Sichuan Xieli Pharmaceutical
23 1Sterling Spa
24 1Sun Pharmaceutical Industries Limited
25 1Tecoland Corporation
26 1Vannsh Life Sciences
27 1Zhejiang Tianyu Pharmaceutical Co., Ltd
01 10China
02 1Finland
03 14India
04 1Iran
05 1Italy
06 4U.S.A
01 11Active
02 20Blank
01 31Blank
01 31Blank
01 1WC-0349
02 1WC-0349A3
03 29Blank
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39757
Submission : 2024-03-22
Status : Active
Type : II
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-04-17
Pay. Date : 2020-02-27
DMF Number : 34437
Submission : 2020-02-25
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38207
Submission : 2023-03-31
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39785
Submission : 2024-03-26
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39141
Submission : 2023-12-01
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 27 companies offering Cabozantinib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?